Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?

BACKGROUND: Introduction of the 7-valent pneumococcal conjugate vaccine (7vCRM) in several countries has led to a rapid, significant drop in vaccine-type invasive pneumococcal disease (IPD) in immunized children. In the United States and some other countries with high antibiotic use, a subsequent ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Hausdorff, William P, Hoet, Bernard, Schuerman, Lode
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829470/
https://www.ncbi.nlm.nih.gov/pubmed/20122261
http://dx.doi.org/10.1186/1471-2431-10-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829470/
https://www.ncbi.nlm.nih.gov/pubmed/20122261
http://dx.doi.org/10.1186/1471-2431-10-4

Ejemplares similares